• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383715
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Pain (1994); Swelling/ Edema (4577)
Event Date 06/28/2023
Event Type  Injury  
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after use with bd pegasus plus¿ closed needle protection iv catheter system patient considered to have phlebitis within 48 hours of use.Hirudoid was applied.The following information was provided by the initial reporter, translated from chinese to english: the head nurse of the gynecology department reported that after the product was used by patients, bloodstream infections occurred and the same bacteria were detected and cultured.Due to the high frequency of occurrence, the hospital suspected that the product was contaminated by bacteria, and hoped that bd company could help it detect whether there was bacterial contamination in the product.Additional information received from the sales representative, and the description of the incident was updated as follows: this patient was considered to have phlebitis.The patient has redness, swelling, heat and pain at the puncture point, but no fever in the whole body; appear within 48 hours of catheterization; after the patient developed redness, swelling and heat pain, the indwelling needle was removed, and hirudoid was applied externally, and the patient's condition gradually eased; the indwelling needle is fully packaged before use.
 
Event Description
It was reported that after use with bd pegasus plus¿ closed needle protection iv catheter system patient considered to have phlebitis within 48 hours of use.Hirudoid was applied the following information was provided by the initial reporter, translated from chinese to english: the head nurse of the gynecology department reported that after the product was used by patients, bloodstream infections occurred and the same bacteria were detected and cultured.Due to the high frequency of occurrence, the hospital suspected that the product was contaminated by bacteria, and hoped that bd company could help it detect whether there was bacterial contamination in the product.Additional information received from the sales representative, and the description of the incident was updated as follows: this patient was considered to have phlebitis 1.The patient has redness, swelling, heat and pain at the puncture point, but no fever in the whole body; 2.Appear within 48 hours of catheterization; 3.After the patient developed redness, swelling and heat pain, the indwelling needle was removed, and hirudoid was applied externally, and the patient's condition gradually eased; 4.The indwelling needle is fully packaged before use.
 
Manufacturer Narrative
H.6.Investigation summary: in response to the event reported a device history review was conducted for lot number 2335073.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Additionally, used samples cannot be tested for biological contamination that occured prior to the opening of hte package.This lot was treated and received a certificate of conformance for sterility.Unfortunately, without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.Bd will continue to monitor this issue.H3 other text : see h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH 
Manufacturer (Section G)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH  
Manufacturer Contact
jennifer suh
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17368191
MDR Text Key319479818
Report Number3006948883-2023-00082
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number383715
Device Lot Number2335073
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/28/2023
Initial Date FDA Received07/20/2023
Supplement Dates Manufacturer Received08/04/2023
Supplement Dates FDA Received08/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-